跳到正文
原文
Nature Medicine· Lesley A. Inker·· 4 天前AI 评分35

一项关于肾功能下降替代终点的元分析

Addendum: A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

AI 导读

一项元分析研究了肾小球滤过率(GFR)斜率作为肾功能衰竭替代终点的有效性。研究纳入了多项相关研究数据,结果显示GFR斜率与肾功能衰竭进展有显著相关性,可作为评估肾病进展的潜在替代指标。

正文

References

  1. Inker, L. A. et al. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure. Nat. Med. 29, 1867–1876 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Wright, J. T. Jr. et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288, 2421–2431 (2002).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Tufts Medical Center, Boston, MA, USA

    Lesley A. Inker, Shiyuan Miao, Juhi Chaudhari & Ronald D. Perrone

  2. Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA

    Willem Collier, Tom Greene & Benjamin Haaland

  3. Division of Nephrology, Columbia University Medical Center and the New York Presbyterian Hospital, New York, NY, USA

    Gerald B. Appel & Pietro Canetta

  4. George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia

    Sunil V. Badve, Brendon L. Neuen, Mark Woodward, John Chalmers, Bruce Neal, Vlado Perkovic, David Johnson & Meg Jardine

  5. Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain

    Fernando Caravaca-Fontán, Hernando Trujillo, Teresa Cavero & Angel Sevillano

  6. Department of Nephrology and Dialysis, Sant’Anna Hospital, ASST Lariana, Como, Italy

    Lucia Del Vecchio

  7. Division of Nephrology, RWTH Aachen University, Aachen, Germany

    Jürgen Floege & Thomas Rauen

  8. Department of Nephrology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

    Marian Goicoechea, Eduardo Verde, Ursula Verdalles & David Arroyo

  9. Medical Research Council Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK

    William G. Herrington

  10. Nakayamadera Imai Clinic, Takarazuka, Japan

    Enyu Imai

  11. Program in Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore

    Tazeen H. Jafar

  12. Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA

    Julia B. Lewis & Jamie Dwyer

  13. Division of Nephrology, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China

    Philip K. T. Li, Kai-Ming Chow, Cheuk-Chun Szeto & Chi-Bon Leung

  14. Department of Nephrology, AZ Delta, Roeselare, Belgium

    Bart D. Maes

  15. Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy

    Giuseppe Remuzzi, Piero Ruggenenti, Annalisa Perna & Fabiola Carrara

  16. Renal, Dialysis and Transplant Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy

    Francesco P. Schena & Carlo Manno

  17. Renal Research Unit, Comprehensive Heart Failure Center, Department of Clinical Research and Epidemiology, University of Würzburg, Würzburg, Germany

    Christoph Wanner

  18. Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands

    Jack F. M. Wetzels

  19. George Institute for Global Health, School of Public Health, Imperial College London, London, UK

    Mark Woodward

  20. Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

    Hiddo J. L. Heerspink

  21. Denver Health, Denver, CO, USA

    Raymond O. Estacio, Rebecca Hanratty, Di Xie & Fan Fan Hou

  22. Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, Canada

    Brendan Barrett

  23. Department of Medicine, Stanford Center for Clinical Research, Stanford University School of Medicine, Stanford, CA, USA

    Kenneth W. Mahaffey

  24. Boehringer Ingelheim International, Ingelheim, Germany

    Maximilian von Eynatten

  25. Section of Nephrology, University of Chicago School of Medicine, Chicago, IL, USA

    Arlene Chapman

  26. Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA

    Vicente Torres

  27. Department of Medicine, Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS, USA

    Alan Yu

  28. Division of Diseases and Hypertension, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, USA

    Godela Brosnahan

  29. Department of Nephrology Dialysis and Renal Transplantation, Alessandro Manzoni Hospital, Lecco, Italy

    Thierry Hannedouche, Giuseppe Maschio, Francesco Locatelli, Simeone Andrulli, Claudio Pozzi & Donatella Casartelli

  30. Cleveland Clinic Foundation, Cleveland, OH, USA

    Marc A. Pohl

  31. Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel

    Itamar Raz

  32. Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA, USA

    Lawrence G. Hunsicker

  33. Department of Nephrology, Heilig Hartziekenhuis Roeselare-Menen, Roeselare, Belgium

    An Vanacker

  34. Renal Division, Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium

    Thomas Malfait

  35. Department of Nephrology & Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands

    Peter J. Blankestijn & Arjan van Zuilen

  36. Daiichi Sankyo, Tokyo, Japan

    Fumiaki Kobayashi

  37. Department of Medicine, Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

    Hirofumi Makino

  38. Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China

    Juliana C. N. Chan

  39. Department of Nephrology, Hospital Universitario 12 de Octubre, Department of Medicine, Complutense University, Madrid, Spain

    Manuel Praga

  40. Merck & Co., Inc., Merck Research Laboratories, Upper Gwynedd, North Wales, PA, USA

    William F. Keane

  41. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK

    Richard Haynes, William G. Herrington, Colin Baigent & Martin Landray

  42. Division of Nephrology and Clinical Immunology, RWTH Aachen University Hospital, Aachen, Germany

    Claudia Seikrit

  43. Department of Medical Statistics, RWTH Aachen University, Aachen, Germany

    Stefanie Wied

  44. Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA

    Robert D. Toto

  45. Departments of Nephrology, University of Groningen, Groningen, The Netherlands

    Paul E. de Jong

  46. Department of Nephrology, St. Donato Hospital, Arezzo, Italy

    Mauro Saddelli

Authors

  1. Lesley A. Inker
  2. Willem Collier
  3. Tom Greene
  4. Shiyuan Miao
  5. Juhi Chaudhari
  6. Gerald B. Appel
  7. Sunil V. Badve
  8. Fernando Caravaca-Fontán
  9. Lucia Del Vecchio
  10. Jürgen Floege
  11. Marian Goicoechea
  12. Benjamin Haaland
  13. William G. Herrington
  14. Enyu Imai
  15. Tazeen H. Jafar
  16. Julia B. Lewis
  17. Philip K. T. Li
  18. Bart D. Maes
  19. Brendon L. Neuen
  20. Ronald D. Perrone
  21. Giuseppe Remuzzi
  22. Francesco P. Schena
  23. Christoph Wanner
  24. Jack F. M. Wetzels
  25. Mark Woodward
  26. Hiddo J. L. Heerspink

Consortia

the CKD-EPI Clinical Trials Consortium

  • Raymond O. Estacio
  • , Rebecca Hanratty
  • , John Chalmers
  • , Pietro Canetta
  • , Brendan Barrett
  • , Bruce Neal
  • , Vlado Perkovic
  • , Kenneth W. Mahaffey
  • , David Johnson
  • , Meg Jardine
  • , Maximilian von Eynatten
  • , Eduardo Verde
  • , Ursula Verdalles
  • , David Arroyo
  • , Arlene Chapman
  • , Vicente Torres
  • , Alan Yu
  • , Godela Brosnahan
  • , Thierry Hannedouche
  • , Kai-Ming Chow
  • , Cheuk-Chun Szeto
  • , Chi-Bon Leung
  • , Di Xie
  • , Fan Fan Hou
  • , Jamie Dwyer
  • , Marc A. Pohl
  • , Itamar Raz
  • , Lawrence G. Hunsicker
  • , An Vanacker
  • , Thomas Malfait
  • , Giuseppe Maschio
  • , Francesco Locatelli
  • , Peter J. Blankestijn
  • , Arjan van Zuilen
  • , Fumiaki Kobayashi
  • , Hirofumi Makino
  • , Juliana C. N. Chan
  • , Simeone Andrulli
  • , Claudio Pozzi
  • , Donatella Casartelli
  • , Manuel Praga
  • , Hernando Trujillo
  • , Teresa Cavero
  • , Angel Sevillano
  • , Piero Ruggenenti
  • , Annalisa Perna
  • , Fabiola Carrara
  • , William F. Keane
  • , Carlo Manno
  • , Richard Haynes
  • , William G. Herrington
  • , Colin Baigent
  • , Martin Landray
  • , Thomas Rauen
  • , Claudia Seikrit
  • , Stefanie Wied
  • , Robert D. Toto
  • , Paul E. de Jong
  •  & Mauro Saddelli

Corresponding author

Correspondence to Lesley A. Inker.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inker, L.A., Collier, W., Greene, T. et al. Addendum: A meta-analysis of GFR slope as a surrogate endpoint for kidney failure. Nat Med (2026). https://doi.org/10.1038/s41591-026-04798-5

Download citation

  • Published: 16 November 2026

  • Version of record: 16 November 2026

  • DOI: https://doi.org/10.1038/s41591-026-04798-5

来源:Nature Medicine · nature.com